SeraSeq reference materials support non-invasive cfDNA screening methods [0.03%]
用于非侵入性cfDNA筛查方法的SeraSeq参考材料
Sylvie Giroux,Seyedeh Saideh Daryabari,André Caron et al.
Sylvie Giroux et al.
Background: Reference materials are essential for the validation, verification, and implementation of clinical assays. Seracare has developed the Seraseq line-commercial reference standards for non-invasive prenatal testi...
A large-scale survey on the knowledge, attitude, and practice of patient-based real-time quality control in China [0.03%]
中国基于患者的实时质量控制的大规模调查：知识、态度和行为
Dong Leng,Mengxue Lyu,Li Wei et al.
Dong Leng et al.
Objectives: Patient-based real-time quality control (PBRTQC) plays a promising role in monitoring the quality of medical laboratory testing processes worldwide. In contrast with traditional quality control, PBRTQC demonst...
A novel Gasdermin D C-terminal neo-epitope as a biomarker for pyroptosis in sepsis [0.03%]
气腹症新表位作为脓毒症中细胞焦亡生物标志物的研究
Jun Li,Yunyun Luo,Ying Liu et al.
Jun Li et al.
Background: Gasdermin D (GSDMD)-mediated pyroptosis, a critical component of the innate immune response, is triggered by pathogenic microbial infections and plays a key role in host defense mechanisms. This process involv...
The hemopexin-apolipoprotein B product: a novel biomarker integrating oxidative stress and lipid metabolism for coronary artery disease risk stratification [0.03%]
整合氧化应激和脂质代谢的冠状动脉疾病风险分层的新生物标志物：血红素结合蛋白-载脂蛋白B产物
Yinsheng Jin,Kun Chen,Qunxiong Fan
Yinsheng Jin
Objective: We hypothesized that the Hemopexin-Apolipoprotein B product (Hpx·apoB), a composite biomarker integrating lipid dysregulation and oxidative stress pathways, would improve coronary artery disease (CAD) diagnosi...
Decoding the interference: How therapeutic monoclonal antibodies challenge serum protein electrophoresis and immunofixation [0.03%]
解读干扰：治疗性单克隆抗体如何挑战血清蛋白电泳和免疫固定电泳
Julie Milandri,Marine Jaillard,Mariette Laffineur et al.
Julie Milandri et al.
Introduction: Serum protein electrophoresis and immunofixation electrophoresis are routinely used to diagnose and monitor monoclonal gammopathies. However, several therapeutic monoclonal antibodies are detectable by these...
Corrigendum to "Optimization and validation of the Kairos Amino Acid Kit for plasma amino acid monitoring in inherited metabolic disorder patients" [Clin. Biochem. 138 (2025) 110960] [0.03%]
“凯罗斯氨基酸试剂盒在遗传代谢病患者血浆氨基酸监测中的优化与验证”一文的勘误注释
Kiara Theron,Jeannette Gauthier,Marijn Van Hulle et al.
Kiara Theron et al.
Published Erratum
Clinical biochemistry. 2025 Nov 4:111036. DOI:10.1016/j.clinbiochem.2025.111036 2025
Diagnosis of patients with IgM monoclonal gammopathy due to analytical interference [0.03%]
分析干扰导致IgM单克隆丙球血症患者的诊断
Ricardo Rubio-Sánchez,Alberto Izquierdo-Martínez,Sara Martínez-Rodríguez et al.
Ricardo Rubio-Sánchez et al.
Introduction: Blood hyperviscosity is a condition associated, in most cases, with Waldenström's macroglobulinemia (WM) and other plasma cell dyscrasias, primarily due to the pentameric structure of immunoglobulin (Ig) M....
Assessment of serum sST2 for cardiac involvement in idiopathic inflammatory myopathies [0.03%]
评估血清sST2在特发性炎性肌病心肌受累中的价值
Liubing Li,Ying Yuan,Siting Yi et al.
Liubing Li et al.
Objective: To assess the diagnostic performance of soluble growth stimulation-expressed gene 2 (sST2) for cardiac involvement in patients with idiopathic inflammatory myopathies (IIMs). ...
A novel 17.9 kb deletion of the beta-globin gene causing beta-thalassemia trait in a Danish male [0.03%]
一种新的17.9 kb的β-珠蛋白基因缺失导致一名丹麦男性的β-地中海贫血症狀群
Helle Pilgaard Kristiansen,Jesper Petersen,Peter Schou et al.
Helle Pilgaard Kristiansen et al.
Background: Beta-thalassemia is a common monogenic disease, especially in malaria-endemic areas. It is mainly caused by point mutations in the beta-globin gene (HBB) while large deletions are more rarely described. Here, ...
The contribution of IL-10 and IL-6 as potential biomarkers for detecting central nervous system involvement in non-Hodgkin lymphomas [0.03%]
检测非霍奇金淋巴瘤中枢神经系统受累的IL-10和IL-6潜在生物标志物的作用
Elisa Buzzatti,Fabiana Esposito,Maria Morello et al.
Elisa Buzzatti et al.
Introduction: A significant clinical challenge in the management of hematologic malignancies is the occurrence of central nervous system (CNS) involvement. In non-Hodgkin lymphoma (NHL), it occurs in varying percentages d...